At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Feb 25, 2026 at 19:00 ET
Teva executives executed derivative exercises and received share grants totaling $0 in cash value, with only two open-market sales: EVP Shields sold $547.7K and Interim CLO Savage sold $35.7K. The cluster is dominated by non-cash, routine compensation activities, with minimal open-market selling.
- EVP Shields sold $547,705 in open-market shares, the largest cash transaction in the cluster.
- Interim CLO Savage sold $35,690 in open-market shares.
- All other transactions were non-cash: derivative exercises (M), grants (A), or awards with $0 value.
- CEO Francis received a grant of 136,736 shares; CFO Kalif and other executives exercised derivatives but did not sell shares.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access